EdiGene is a series b startup based in China. 1 investor tracked.
EdiGene is a company founded in 2018 headquartered in China. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
EdiGene is a biotechnology company focused on developing gene-editing technologies for therapeutic applications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.